BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
12.55
-0.43 (-3.31%)
Jan 29, 2026, 4:00 PM EST - Market closed
BBOT Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$23.83
Upside
+89.88%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Initiates $24 | Buy | Initiates | $24 | +91.24% | Jan 9, 2026 |
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +99.20% | Dec 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $20 | Buy | Initiates | $20 | +59.36% | Dec 5, 2025 |
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +99.20% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +75.30% | Nov 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +99.20% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +115.14% | Sep 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $23 | Buy | Initiates | $23 | +83.27% | Sep 4, 2025 |
| Wedbush | Wedbush | Buy Initiates $25 | Buy | Initiates | $25 | +99.20% | Aug 18, 2025 |